oxprenolol has been researched along with Remission, Spontaneous in 1 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rackensperger, W | 1 |
| Gaupp, R | 1 |
| Mattke, DJ | 1 |
| Schwarz, D | 1 |
| Stutte, KH | 1 |
1 trial available for oxprenolol and Remission, Spontaneous
| Article | Year |
|---|---|
[Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Blood Pressure; Catatonia; Clinical Trials as Top | 1974 |